University of Southampton
SOTON has a long history of innovative, patient facing clinical research into the pathophysiology of airway disease and novel therapies with many projects taking an omic approach.
Role within 3TR
Southampton is working across the respiratory WP8 element (“COPD/Asthma”) of the project. They are leading Task 8.6 (“Determination of therapeutic response: clinical, biological, PROs”) and are working along others partners in WP5 (“Cross Disease Activities”).